Skip to main content
. 2021 Apr 15;22(8):4098. doi: 10.3390/ijms22084098

Figure 4.

Figure 4

Loss of NEIL3 promotes cisplatin resistance by alleviating S-phase block. (AC) Representative flow cytometry cell cycle images of DU145 before and after cisplatin treatment. (D) Relative S-phase change curves for DU145 after cisplatin treatment, **** p < 0.0001, versus the corresponding time point negative control (NC) group.